Z tego co znalazłam aktualne jest badanie w Heidelbergu, dotyczy ono Glivecu (IMATINIB).
EudraCT Number: 2007-000624-40
Sponsor Protocol Number: CSTI571BDE70
Sponsor Name: University of Heidelberg
Full Title: PHASE II STUDY TO EVALUATE GLIVEC (IMATINIB MESYLATE) TO INDUCE PROGRESSION ARREST IN AGGRESSIVE FIBROMATOSIS / DESMOID TUMORS NOT AMENABLE TO SURGICAL RESECTION WITH R0 INTENT OR ACCOMPANIED BY UN...
Start Date: 2010-05-27
Medical condition: AGGRESSIVE FIBROMATOSIS / DESMOID TUMORS
Population Age: Adults, Elderly
Gender: Male, Female
Country: DE(Ongoing)
Link: https://www.clinicaltrial...:2007-000624-40